Results (4286)
Non-interventional Post-Authorisation Safety Study of Burosumab in the Treatment of Children >1 year of age, Adolescents and Adults with X-Linked Hypophosphataemia (XLH PASS)
Belgium
Bulgaria
Czechia
Denmark
France
Germany
Hungary
Ireland
Israel
Italy
Latvia
Netherlands
Norway
Portugal
Slovakia
Slovenia
Spain
Sweden
Switzerland
United Kingdom
United Kingdom (Northern Ireland)
EU PAS number:
EUPAS32190
First published:
19/05/2025
StudyOngoing
European Observational Cohort Study of delayed union and non-union fractures of long bones. (COHORTHO-UNION)
France
Germany
Italy
Spain
EU PAS number:
EUPAS1000000535
First published:
19/05/2025
StudyOngoing
Norwegian Linked Health registry at University of Oslo
First published:
19/05/2025
Norway
Data source
Human
Birth registryDeath registryDisease registryHospital inpatient recordsHospital outpatient visit recordsPharmacy dispensing recordsPopulation registryPrimary care medical recordsVaccination registryNorwegian Linked Health registry at University of Oslo, Pregnancy cohort
First published:
19/05/2025
Norway
Data source
Human
Birth registryHospital inpatient recordsHospital outpatient visit recordsPharmacy dispensing recordsPrimary care medical recordsCohort Study of Long-term Safety of Upadacitinib in the Treatment of Atopic Dermatitis in Denmark and Sweden
Denmark
Sweden
EU PAS number:
EUPAS49230
First published:
19/05/2025
StudyOngoing
Danish Health Data Registries
First published:
16/05/2025
Denmark
Data source
Human
Cancer registryDeath registryHospital inpatient recordsHospital outpatient visit recordsOtherPharmacy dispensing recordsPopulation registryVaccination registryThe Cancer Registry of Norway
First published:
16/05/2025
Norway
Data source
Human
Cancer registryDisease registryInGef Research Database
First published:
16/05/2025
Germany
Data source
Human
Administrative healthcare records (e.g., claims)UK National Neonatal Research Database
First published:
16/05/2025
Isle of Man
United Kingdom
Data source
Human
OtherHealth Data Research Platform of the Balearic Islands (PRISIB)
First published:
16/05/2025
Spain
Data source
Human
Hospital inpatient recordsPharmacy dispensing recordsPrimary care medical recordsIATROS
First published:
16/05/2025
France
Data source
Human
Hospital inpatient recordsHospital outpatient visit recordsOtherHealth Data Architecture for Learning, INFOBANCO
First published:
16/05/2025
Spain
Data source
Human
OtherPopulation registryPrimary care medical recordsResearch Repository @Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
First published:
16/05/2025
Italy
Data source
Human
Hospital discharge recordsHospital inpatient recordsHospital outpatient visit recordsOtherOM1
Netherlands
United States
First published:
16/05/2025
InstitutionNon-Pharmaceutical companyENCePP partner
Non-interventional post-authorization study of belzutifan in adult patients with von Hippel-Lindau disease-associated renal cell carcinoma, pancreatic neuroendocrine tumor and/or central nervous system hemangioblastoma (MK-6482-026)
Canada
United States
EU PAS number:
EUPAS108114
First published:
16/05/2025
StudyOngoing
Prospective observational investigation of possible correlations between change in FVC and change in cough or dyspnea scores using the living with pulmonary fibrosis questionnaire (L-PF) between baseline and after approximately 52 weeks of nintedanib treatment in patients suffering from chronic fibrosing ILD with a progressive phenotype. (INREAL)
Germany
EU PAS number:
EUPAS38272
First published:
15/05/2025
StudyFinalised
A Longitudinal, Retrospective, Multi-centre Observational Study to Evaluate Effectiveness, Persistence, Treatment Patterns and Safety of Australian Patients Receiving Early Access to Tofacitinib
Australia
EU PAS number:
EUPAS41439
First published:
15/05/2025
StudyOngoing
Fezolinetant Experience for the Treatment of Vasomotor Symptoms Associated with Menopause Among Women in a German Real-life Setting
Germany
EU PAS number:
EUPAS1000000132
First published:
15/05/2025
StudyOngoing
OBSERVATIONAL SAFETY AND EFFECTIVENESS STUDY OF PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB
Germany
United States
EU PAS number:
EUPAS10547
First published:
15/05/2025
StudyOngoing
Non-interventional post-authorization effectiveness study to assess long-term outcomes of Nintedanib treatment in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) (Nintedanib long-term outcomes in patients with SSc)
Argentina
Armenia
Austria
Belgium
Brazil
Bulgaria
Canada
China
Croatia
Czechia
Denmark
Dominican Republic
Egypt
Estonia
Finland
France
Germany
Greece
Hungary
Iran, Islamic Republic of
Ireland
Israel
Italy
Japan
Lithuania
Malta
Moldova, Republic of
Montenegro
Netherlands
New Zealand
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovenia
South Africa
Spain
Sweden
Switzerland
Türkiye
Ukraine
United Kingdom
United States
EU PAS number:
EUPAS106792
First published:
15/05/2025
StudyPlanned
A comparative observational study to evaluate the safety and effectiveness of Xromi® (hydroxycarbamide oral solution 100mg/ml) for the prevention of vaso-occlusive complications of sickle cell disease in children under 2 years of age. [PRECISE PASS]
Germany
United Kingdom
EU PAS number:
EUPAS1000000076
First published:
15/05/2025
StudyPlanned
Assessing the cost-effectiveness of Smartinhaler technology in primary care: a health economic decision Model in school-Aged children (SMART-MOD)
United Kingdom
EU PAS number:
EUPAS1000000556
First published:
15/05/2025
StudyPlanned
Survey among healthcare professionals (neurologists treating patients with MS along with MS specialist nurses) and patients in selected European countries plus Canada to evaluate the knowledge required for the safe use of Mayzent (siponimod)
Canada
Croatia
Denmark
Germany
Netherlands
Spain
Sweden
EU PAS number:
EUPAS44782
First published:
15/05/2025
StudyOngoing
Plasma concentration of lidocaine and its metabolites after topical application of Lidocaine dental gel 15% w/v to the oral mucosa
Greece
EU PAS number:
EUPAS1000000582
First published:
15/05/2025
StudyFinalised
Nationwide analysis of the breast cancer guidelines adherence in Bulgaria
Bulgaria
EU PAS number:
EUPAS1000000571
First published:
15/05/2025
StudyFinalised
Long-term, Non-interventional Study of Recipients of Tecartus for Treatment of Adult Patients With Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL) or Adult Patients With R/R B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)
Austria
Czechia
France
Germany
Israel
Italy
Netherlands
Poland
Portugal
Spain
Switzerland
United Kingdom
United States
EU PAS number:
EUPAS45813
First published:
15/05/2025
StudyOngoing
DARWIN EU® - Characterising the use of JAK inhibitors in Europe: a Drug Utilisation Study
Finland
Germany
Netherlands
Norway
Spain
EU PAS number:
EUPAS1000000424
First published:
15/05/2025
StudyFinalised
DARWIN EU® - Prevalence of hypertrophic cardiomyopathy (HCM) and obstructive hypertrophic cardiomyopathy (oHCM) in six European countries
Croatia
Denmark
Germany
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000430
First published:
14/05/2025
StudyFinalised
CLINICAL RESEARCH UNIT, SCHOOL OF MEDICINE, PAPAGEORGIOU GENERAL HOSPITAL, ARISTOTLE UNIVERSITY OF THESSALONIKI (CRU-AUSoM)
Greece
First published:
13/05/2025
InstitutionEducational InstitutionHospital/Clinic/Other health care facilityLaboratory/Research/Testing facilityENCePP partner
Drug Utilization Study Evaluating Additional Risk Minimisation Measures for Upadacitinib in the Treatment of Ulcerative Colitis in Europe
Denmark
Spain
Sweden
EU PAS number:
EUPAS107885
First published:
12/05/2025
StudyOngoing
Real-world Study on Bemiparin Effect in Patients with Cancer-Associated Thromboembolism Using Artificial Intelligence (BEMICAT Study)
Spain
EU PAS number:
EUPAS1000000578
First published:
12/05/2025
StudyOngoing
Prospective non-interventional cohort study to assess safety and tolerability of 3Fluart 2025/2026 trivalent seasonal influenza vaccine in children, adolescents, adults and elderly subjects (3Fluart-H-36)
Hungary
EU PAS number:
EUPAS1000000581
First published:
12/05/2025
StudyPlanned
Clinical Characteristics, Including History of MI and Stroke, Among US Post-menopausal Women Initiating Treatment With Romosozumab and Other Anti-osteoporosis Therapies (20190205)
United States
EU PAS number:
EUPAS37160
First published:
12/05/2025
StudyFinalised
Overall survival and incidence of adverse events in B-cell acute lymphoblastic leukemia (ALL) patients after allogeneic stem cell transplant: blinatumomab vs non-blinatumomab chemotherapy-- an analysis of the Center for International Blood and Marrow Transplant Research database (20170610) (Transplant outcomes among ALL in CIBMTR)
Austria
Belgium
Bulgaria
Canada
Croatia
Cyprus
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS33745
First published:
12/05/2025
StudyFinalised
Tarlatamab vs. Real-world Physicians’ Choice Therapies in Patients with Relapsed or Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment: Patient-level Indirect Treatment Comparison (ITC) of DeLLphi-301 vs. Flatiron Real-world Data (20240049)
United States
EU PAS number:
EUPAS1000000298
First published:
12/05/2025
StudyFinalised
Retrospective Cohort Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
United States
EU PAS number:
EUPAS45952
First published:
12/05/2025
StudyOngoing
Tafamidis Pregnancy Surveillance Study
Canada
France
Germany
Japan
Portugal
Spain
United Kingdom
United States
EU PAS number:
EUPAS37119
First published:
12/05/2025
StudyOngoing
LONG-TERM NON-INTERVENTIONAL SAFETY STUDY OF EMICIZUMAB TREATMENT IN PATIENTS WITH MODERATE HAEMOPHILIA A AND SEVERE BLEEDING PHENOTYPE (STUDY BO44691, PASS)
Canada
France
United Kingdom
United States
EU PAS number:
EUPAS1000000174
First published:
12/05/2025
StudyPlanned
A regulatory requirement non-interventional study to monitor the safety and effectiveness of Spesolimab in Korean patients with flares with generalized pustular psoriasis
Korea, Republic of
EU PAS number:
EUPAS1000000278
First published:
12/05/2025
StudyPlanned